icon
沙特阿拉伯王国政府所属的官方政府网站。
icon 周四 25 6月 2026
icon
沙特官方政府网站的域名以下列后缀结尾 gov.sa

沙特阿拉伯王国所有政府机构的官方网站均以 .gov.sa 结尾。

icon
政府网站使用以下协议。 HTTPS 用于加密和安全。

沙特阿拉伯王国所有政府机构的官方网站均以 .gov.sa 结尾。

icon
在数字政府管理局注册,编号:
20250831619
建议

Recall of batch No. 1407169 of the product: Xeractan 20 mg

القسم

Drugs

violet
drugs

Recall of batch No. 1407169 of the product: Xeractan 20 mg

icon 2026-04-20
الاسم التجاري الاسم العلمي رقم التسجيل رقم التشغيلة المتأثرة الشركة الصانعة Trade Name Scientific Name Register Number Affected batch number Manufacturer Xeractan 20 mg soft gelatin capsule Isotretinoin 2805257489 1407169 GAP SA PHARMACEUTICAL
التصنيف
ملف
التاريخ
2026-04-16
اسم المستحضر
Xeractan 20 mg soft gelatin capsule
اجراء الاستدعاء
مستوى الاستدعاء
نوع المستحضر
سبب السحب

The Saudi Food and Drug Authority (SFDA) has issued a recall of batch No. 1407169 of the product Xeractan 20 mg soft gelatin capsules due to out-of-specification results observed during stability studies, which may impact the product’s quality and safety.

التوصيات

For healthcare professionals: Stop dispensing the batch immediately. Embargo/Quarantine all remaining stock. Affected batch should be returned to the supplier.

For patients,

  1. Consult your healthcare provider prior to discontinuing use of the affected batchor for any health concerns.

  2. Contact the recalling firm or SFDA if you have any questions about the recall.
  3. Adverse reactions or quality problems experienced with the use of this product may be reported to Saudi Vigilance either online or call center (Call 19999).